Symbol
Adaptive Biotechnologies Corporation
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$7.47
Current price of the stock
$3M
Trading volume of the stock
$1.1B
Market capitalization of the company
Small Cap
Category of market capitalization
13.90%
Long-term growth mean estimate
4.75
Mean analyst rating
30.04%
Potential price appreciation based on analyst price targets
11.54%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.52
Current ratio
64.11%
Gross profit margin
-70.27%
Operating profit margin
-70.27%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-69.12%
Pretax profit margin
-69.07%
Net profit margin
-14.36%
Measures profitability relative to shareholders' equity
-31.86%
ROE excluding intangible assets
-5.75%
Measures profitability relative to total assets
-14.36%
Measures profitability relative to invested capital
0.08
Asset turnover ratio
1.39
Inventory turnover ratio
1.14
Receivables turnover ratio
79.11
Average number of days it takes to collect receivables
-5.57
Measures valuation relative to earnings
-5.70
P/E based on future earnings estimates
6.22
Measures valuation relative to sales
4.93
Measures valuation relative to book value
-3.27
Measures valuation relative to operating cash flow
-3.09
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC